San Diego, CA
Replicate Bioscience creates novel oncology treatments to prevent and reverse drug resistance through a self-replicating RNA platform called SynRGY. By deploying SynRGY technology, the company aims to design novel treatments that prevent the occurrence of drug resistance and create solutions that enhance the effectiveness of many immuno-oncology regimens.
replicatebioscience.comThese are collections Replicate Bioscience is a part of. Click on the collection name to view similar companies.
Series A
$40,000,000
Seed
$6,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Replicate Bioscience.